Exact Sciences Stock Analysis
EXAS Stock | USD 63.48 0.26 0.41% |
EXACT Sciences is undervalued with Real Value of 74.42 and Target Price of 106.38. The main objective of EXACT Sciences stock analysis is to determine its intrinsic value, which is an estimate of what EXACT Sciences is worth, separate from its market price. There are two main types of EXACT Sciences' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect EXACT Sciences' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of EXACT Sciences' stock to identify patterns and trends that may indicate its future price movements.
The EXACT Sciences stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. EXACT Sciences is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. EXACT Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and EXACT Sciences' ongoing operational relationships across important fundamental and technical indicators.
EXACT |
EXACT Stock Analysis Notes
About 89.0% of the company shares are held by institutions such as insurance companies. The book value of EXACT Sciences was currently reported as 17.34. The company recorded a loss per share of 1.13. EXACT Sciences had not issued any dividends in recent years. Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin. Exact Sciences operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 6420 people. To learn more about EXACT Sciences call Kevin Conroy at 608 284 5700 or check out https://www.exactsciences.com.EXACT Sciences Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. EXACT Sciences' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding EXACT Sciences or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
EXACT Sciences generated a negative expected return over the last 90 days | |
The company reported the previous year's revenue of 2.5 B. Net Loss for the year was (204.15 M) with profit before overhead, payroll, taxes, and interest of 1.51 B. | |
EXACT Sciences has a poor financial position based on the latest SEC disclosures | |
Over 89.0% of the company shares are held by institutions such as insurance companies | |
Latest headline from zacks.com: Why Exact Sciences Dipped More Than Broader Market Today |
EXACT Sciences Upcoming and Recent Events
Earnings reports are used by EXACT Sciences to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to EXACT Sciences previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
20th of February 2024 Upcoming Quarterly Report | View | |
14th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
20th of February 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
EXACT Largest EPS Surprises
Earnings surprises can significantly impact EXACT Sciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2011-05-03 | 2011-03-31 | -0.09 | -0.08 | 0.01 | 11 | ||
2010-10-27 | 2010-09-30 | -0.07 | -0.08 | -0.01 | 14 | ||
2010-05-06 | 2010-03-31 | -0.05 | -0.06 | -0.01 | 20 |
EXACT Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as EXACT Sciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading EXACT Sciences backward and forwards among themselves. EXACT Sciences' institutional investor refers to the entity that pools money to purchase EXACT Sciences' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Ameriprise Financial Inc | 2023-12-31 | 2.5 M | Sumitomo Mitsui Trust Holdings Inc | 2023-12-31 | 2.2 M | Amvescap Plc. | 2023-12-31 | 2.2 M | Allspring Global Investments Holdings, Llc | 2023-12-31 | 1.9 M | Goldman Sachs Group Inc | 2023-12-31 | 1.8 M | Nikko Asset Management Americas Inc | 2023-12-31 | 1.8 M | Citadel Advisors Llc | 2023-09-30 | 1.7 M | Norges Bank | 2023-12-31 | 1.6 M | Ensign Peak Advisors Inc | 2023-12-31 | 1.5 M | Vanguard Group Inc | 2023-12-31 | 17.6 M | Jpmorgan Chase & Co | 2023-12-31 | 16.7 M |
EXACT Market Capitalization
The company currently falls under 'Large-Cap' category with a current market capitalization of 11.52 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate EXACT Sciences's market, we take the total number of its shares issued and multiply it by EXACT Sciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.EXACT Profitablity
EXACT Sciences' profitability indicators refer to fundamental financial ratios that showcase EXACT Sciences' ability to generate income relative to its revenue or operating costs. If, let's say, EXACT Sciences is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, EXACT Sciences' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of EXACT Sciences' profitability requires more research than a typical breakdown of EXACT Sciences' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.08) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.12) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.12. Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.09) | (0.1) | |
Return On Capital Employed | (0.04) | (0.04) | |
Return On Assets | (0.03) | (0.03) | |
Return On Equity | (0.06) | (0.07) |
Management Efficiency
EXACT Sciences has return on total asset (ROA) of (0.0304) % which means that it has lost $0.0304 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.066) %, meaning that it created substantial loss on money invested by shareholders. EXACT Sciences' management efficiency ratios could be used to measure how well EXACT Sciences manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.1 in 2024. Return On Capital Employed is likely to drop to -0.04 in 2024. At this time, EXACT Sciences' Debt To Assets are comparatively stable compared to the past year. Asset Turnover is likely to gain to 0.41 in 2024, whereas Return On Tangible Assets are likely to drop (0.1) in 2024.Last Reported | Projected for Next Year | ||
Book Value Per Share | 17.46 | 18.33 | |
Net Current Asset Value | 0.00 | 0.00 | |
Tangible Asset Value | 0.00 | 0.00 | |
Tangible Book Value Per Share | (6.17) | (5.87) | |
Enterprise Value Over EBITDA | -1.2 K | -1.1 K | |
Price Book Value Ratio | 4.24 | 4.47 | |
Enterprise Value Multiple | -1.2 K | -1.1 K | |
Price Fair Value | 4.24 | 4.47 | |
Enterprise Value | 352.5 M | 370.1 M |
The analysis of EXACT Sciences' management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze EXACT Sciences' future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of EXACT Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta 1.232 |
Technical Drivers
As of the 19th of April, EXACT Sciences owns the Market Risk Adjusted Performance of (0.01), standard deviation of 2.89, and Variance of 8.37. EXACT Sciences technical analysis allows you to utilize past data patterns in order to determine a pattern that computes the direction of the firm's future prices. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume patterns, or the prices will eventually revert. We were able to analyze thirteen technical drivers for EXACT Sciences, which can be compared to its peers in the sector. Please confirm EXACT Sciences risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if EXACT Sciences is priced correctly, providing market reflects its prevailing price of 63.48 per share. Given that EXACT Sciences has information ratio of (0.03), we urge you to verify EXACT Sciences's latest market performance to make sure the company can sustain itself in the future.EXACT Sciences Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. EXACT Sciences middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for EXACT Sciences. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
EXACT Sciences Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific EXACT Sciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on EXACT Sciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases EXACT Sciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Jeffrey Elliott over a month ago Acquisition by Jeffrey Elliott of 5701 shares of EXACT Sciences subject to Rule 16b-3 | ||
Katherine Zanotti over six months ago Acquisition by Katherine Zanotti of 5831 shares of EXACT Sciences subject to Rule 16b-3 | ||
Katherine Zanotti over six months ago Acquisition by Katherine Zanotti of 17482 shares of EXACT Sciences subject to Rule 16b-3 | ||
Katherine Zanotti over six months ago Acquisition by Katherine Zanotti of 3599 shares of EXACT Sciences subject to Rule 16b-3 |
EXACT Sciences Outstanding Bonds
EXACT Sciences issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. EXACT Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most EXACT bonds can be classified according to their maturity, which is the date when EXACT Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
US30063PAB13 Corp BondUS30063PAB13 | View | |
US30063PAC95 Corp BondUS30063PAC95 | View |
EXACT Sciences Predictive Daily Indicators
EXACT Sciences intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of EXACT Sciences stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
EXACT Sciences Corporate Filings
8K | 17th of April 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 15th of April 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 3rd of April 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 1st of April 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 4th of March 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 28th of February 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 26th of February 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 23rd of February 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
EXACT Sciences Forecast Models
EXACT Sciences' time-series forecasting models are one of many EXACT Sciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary EXACT Sciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About EXACT Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how EXACT Sciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling EXACT shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as EXACT Sciences. By using and applying EXACT Stock analysis, traders can create a robust methodology for identifying EXACT entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (0.08) | (0.08) | |
Operating Profit Margin | (0.09) | (0.09) | |
Net Loss | (0.08) | (0.09) | |
Gross Profit Margin | 0.74 | 0.76 |
Current EXACT Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. EXACT analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. EXACT analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
106.38 | Strong Buy | 22 | Odds |
Most EXACT analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand EXACT stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of EXACT Sciences, talking to its executives and customers, or listening to EXACT conference calls.
EXACT Stock Analysis Indicators
EXACT Sciences stock analysis indicators help investors evaluate how EXACT Sciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading EXACT Sciences shares will generate the highest return on investment. By understating and applying EXACT Sciences stock analysis, traders can identify EXACT Sciences position entry and exit signals to maximize returns.
Begin Period Cash Flow | 242.8 M | |
Long Term Debt | 2.3 B | |
Common Stock Shares Outstanding | 180.1 M | |
Total Stockholder Equity | 3.1 B | |
Tax Provision | 2.4 M | |
Property Plant And Equipment Net | 842.1 M | |
Cash And Short Term Investments | 777.6 M | |
Cash | 605.4 M | |
Accounts Payable | 78.8 M | |
Net Debt | 1.9 B | |
50 Day M A | 63.2742 | |
Total Current Liabilities | 514.7 M | |
Other Operating Expenses | 2.7 B | |
Non Current Assets Total | 5.3 B | |
Non Currrent Assets Other | -287.5 M | |
Stock Based Compensation | 231.3 M |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in EXACT Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For more information on how to buy EXACT Stock please use our How to Invest in EXACT Sciences guide.Note that the EXACT Sciences information on this page should be used as a complementary analysis to other EXACT Sciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Complementary Tools for EXACT Stock analysis
When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |
Is EXACT Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EXACT Sciences. If investors know EXACT will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EXACT Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.13) | Revenue Per Share 13.876 | Quarterly Revenue Growth 0.17 | Return On Assets (0.03) | Return On Equity (0.07) |
The market value of EXACT Sciences is measured differently than its book value, which is the value of EXACT that is recorded on the company's balance sheet. Investors also form their own opinion of EXACT Sciences' value that differs from its market value or its book value, called intrinsic value, which is EXACT Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EXACT Sciences' market value can be influenced by many factors that don't directly affect EXACT Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EXACT Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if EXACT Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EXACT Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.